Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avaxia Biologics Inc.

www.avaxiabiologics.com

Latest From Avaxia Biologics Inc.

Taking Wing With Biotech Angel Investors

They’re not just for seed rounds anymore: in the life sciences, rich individuals are supplying more early stage capital than ever, occasionally well past the Series A stage, and some are banding together into groups that look increasingly like traditional venture capital. How far will this phenomenon fly?

BioPharmaceutical United States

Execs On The Move, November 2013

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

BioPharmaceutical Medical Device

Start-Up Execs On The Move, November 2013

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device

Start-Up Execs On The Move, September 2013

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Gastrointestinal
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Avaxia Biologics Inc.
  • Senior Management
  • Barbara S Fox, PhD, CEO
    Deborah S Hartman, PhD, VP, Research
    Michael D Rivard, VP, Corp. Dev.
    Harris M. Scott, MD, CMO
    Kevin Sarney, VP, Fin. & Admin.
  • Contact Info
  • Avaxia Biologics Inc.
    Phone: (781) 861-0062
    128 Spring St.
    Ste. 620
    Lexington, MA 02421
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register